v
Search
Advanced
    Original Article Open Access
    Jaundice Is Associated with Intraoperative Hypotension, Suppressed Immune–endothelial NF-κB/EDN1 Signaling, and Impaired Vascular Cell Function
    Gen Li, Ming Cheng, Jian He, Dengfeng Huang, Yingying Zhou, Yaohui Gao, Yuming Sun, Zhizhen Li
    Journal of Clinical and Translational Hepatology, Published online November 17, 2026. doi:10.14218/JCTH.2026.00174
    Abstract
    Intraoperative hypotension (IOH) is a common and serious complication associated with increased perioperative morbidity and mortality. Although obstructive jaundice is often accompanied [...] Read more.

    Intraoperative hypotension (IOH) is a common and serious complication associated with increased perioperative morbidity and mortality. Although obstructive jaundice is often accompanied by hemodynamic instability, its mechanistic contribution to IOH remains unclear. In this study, we aimed to determine whether jaundice affects IOH and elucidate the underlying mechanism.

    Clinical data from 139 patients who underwent pancreatoduodenectomy were retrospectively analyzed for predictors of IOH. Vascular tissues from jaundiced and non-jaundiced patients were subjected to single-cell RNA sequencing for cell-specific molecular exploration. Key findings were validated by immunohistochemistry in a stratified random sample from the study cohort. In a rat bile duct ligation model, aortic endothelin-1 (EDN1) expression and vascular function were assessed by Western blotting and ex vivo vascular reactivity assays. The mechanism was investigated in primary mouse aortic endothelial cells under TNF-α stimulation with or without NF-κB pathway inhibition.

    Multivariable logistic regression identified jaundice as an independent predictor of IOH (odds ratio, 2.328; 95% confidence interval, 1.027–5.276; P = 0.043). Jaundiced tissues exhibited vascular cell remodeling, characterized by increased proportions of endothelial cells and macrophages and decreased proportions of fibroblasts and smooth muscle cells. EDN1 expression was significantly downregulated in jaundiced patients, and total bilirubin levels were negatively correlated with EDN1 protein expression (P < 0.001). Single-cell RNA sequencing of immune cells suggested suppression of the NF-κB pathway in jaundiced patients. In the bile duct ligation model, EDN1 expression in aortic tissue showed a time-dependent decrease. In TNF-α-stimulated primary mouse aortic endothelial cells, bilirubin or NF-κB inhibition with BAY 11-7082 suppressed EDN1 expression.

    Biliary obstruction causing jaundice may contribute to IOH through suppression of NF-κB signaling and reduced endothelial EDN1 expression. These findings support further investigation of the NF-κB/EDN1 signaling axis as a potential therapeutic target for jaundice-associated IOH.

    Full article
    Original Article Open Access
    MOLLI Seed and Surgical Margin Status in Breast-conserving Surgery: An Exploratory Study
    Lucy Ogoke, Sangwook Michael Woo, Nicole Herbers, Michael Chen, Hua Yang, Amy Bazzarelli, Wei Xiong
    Journal of Clinical and Translational Pathology, Published online November 17, 2026. doi:10.14218/JCTP.2026.00043
    Abstract
    Fine-wire-guided localization (FWGL) has traditionally been used for nonpalpable breast lesions although it can complicate specimen handling. Magnetic Occult Lesion Localization [...] Read more.

    Fine-wire-guided localization (FWGL) has traditionally been used for nonpalpable breast lesions although it can complicate specimen handling. Magnetic Occult Lesion Localization and Imaging (MOLLI) is a wire-free alternative for which comparative pathologic data remain limited. This exploratory study examined margin status, morphometry, and specimen integrity.

    We retrospectively analyzed 109 consecutive lumpectomy specimens (83 MOLLI, 26 FWGL) at a single academic center between March 2022 and April 2023, comprising 108 primary excisions and one re-excision. The localization method was not randomly assigned and appears to have depended on surgeon preference. Secondary invasive-carcinoma analyses used Firth penalized logistic regression to adjust for potential confounding.

    After exclusion of 33 benign lesions, 76 carcinomas remained (62 invasive carcinomas and 14 cases of pure ductal carcinoma in situ), 75 with evaluable primary-excision margins. For the primary outcome, positive margins occurred in 13.8% (8/58) of MOLLI versus 17.6% (3/17) of FWGL cases (P = 0.70). In the secondary invasive-carcinoma analysis, positive margins occurred in 10.9% (5/46) versus 18.8% (3/16) (P = 0.41). Median specimen weight and volume did not differ significantly; specimen integrity was preserved in 98.8% (82/83) of MOLLI and 100% (26/26) of FWGL specimens.

    In this exploratory study, MOLLI shows no detectable differences in margin status, morphometry, or specimen integrity relative to fine-wire localization. Unlike published data on a related magnetic-seed device, we observe no reduction in resected tissue volume, indicating that findings for one device should not be assumed to apply to another. The study is underpowered to detect small differences. These preliminary findings therefore require confirmation in larger studies.

    Full article
    Review Article Open Access
    Midnight-noon Ebb-flow (Ziwu Liuzhu) and Circadian Science: Comparison of Two Temporalized Models of the Body
    Kao-Cheng Huang, Ya-Ning Chang
    Future Integrative Medicine, Published online November 17, 2026. doi:10.14218/FIM.2026.00026
    Abstract
    Midnight-noon ebb-flow (ziwu liuzhu) and circadian science are both temporalized models of the body, treating time of day as an intrinsic variable of physiology and therapeutic [...] Read more.

    Midnight-noon ebb-flow (ziwu liuzhu) and circadian science are both temporalized models of the body, treating time of day as an intrinsic variable of physiology and therapeutic response, yet they differ fundamentally in theoretical units, causal claims, and standards of evidence. Ziwu liuzhu, a time-function model of traditional Chinese medicine, maps the 12 double-hours (shichen) onto the ebb and flow of qi and blood in the 12 channels (meridians); circadian science, an experimentally grounded mechanistic model, describes circadian rhythms generated by an endogenous, light-entrained timing system of the suprachiasmatic nucleus, clock genes, and peripheral clocks. Existing accounts tend either to conflate the two frameworks or to dismiss one in terms of the other. This narrative review compares the two frameworks’ conceptual structure, historical formation, mechanisms, evidence, and applications. Their genuine convergence lies in treating time as a variable in health and disease, not in any proven mechanism. Chronotherapy findings likewise do not validate the channel-hour correspondences. Fixed double-hour assignments do not correspond to the phase-adjustable, individually variable circadian system; the morphological basis of the channels remains unconfirmed; and the certainty of evidence for a timing-specific effect of ziwu liuzhu acupuncture appears low to very low. We distinguish three critical issues that are often conflated: the efficacy of timed acupuncture, its mechanism, and the anatomical status of the channels; evidence on the first two does not settle the third. We propose a layered research agenda that preserves the tradition’s historical and clinical value while rigorously evaluating its testable claims, chiefly through trials comparing identical needling given on-time and off-time, scheduled both by classical clock time and relative to measured circadian phase. We conclude that ziwu liuzhu is best treated as a source of testable hypotheses, and that no clinical efficacy should be claimed for its timing principle until it has been demonstrated.

    Full article
All Journals
    Review Article Open Access
    Environmental Triggers’ Involvement in the Development of Type 1 Diabetes Mellitus
    Tajudeen Olanrewaju Yahaya, Umar Usman Liman, Caleb Dikko Obadiah, Zafira Illo Zakari, Daniel Anyebe, Boniface Gomo Clement, Balkisu Marafa Muhammad
    Exploratory Research and Hypothesis in Medicine, Published online July 27, 2022. doi:10.14218/ERHM.2022.00051
    Abstract
    The huge burden of type 1 diabetes mellitus (T1DM) has been a source of concern globally since the Industrial Revolution in the 18th–19th centuries. To this end, studies have shown [...] Read more.

    The huge burden of type 1 diabetes mellitus (T1DM) has been a source of concern globally since the Industrial Revolution in the 18th–19th centuries. To this end, studies have shown that certain environmental changes that accompanied the Revolution may have increased the risk and burden of the disease in genetically predisposed individuals. However, documented studies that synthesize these environmental triggers are scarce. As a result, the current study was conceived to synthesize the environmental triggers of T1DM to boost public awareness. Relevant information was retrieved from reputable academic databases; namely, Scopus, PubMed, SpringerLink, and Embase. The results showed that chemical exposure, viral infection, gut microbiome disruption, vitamin and mineral deficiencies, inadequate or exclusive breastfeeding, as well as early exposure to infant feeding formulas could increase the risk and burden of T1DM in genetically predisposed individuals. As a consequence, these triggers could compromise the expression of certain genes involved in insulin synthesis and immune function, such as the human leukocyte antigen (HLA), insulin (INS), cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), and protein tyrosine phosphatase non-receptor type 22 (PTPN22) genes. This would result in a dysfunctional immune system in which immune cells, such as T-cells and B-cells and molecules, such as cytokines would attack self-tissues, thus causing autoimmunity of the pancreatic beta cells. Environmental triggers could also induce the T1DM pathophysiology by modifying the epigenome of the mentioned genes. Furthermore, some epigenetic changes could be reversed, which would infer that treatment procedures that would include the pathophysiology of the environmental triggers could be more effective.

    Full article
    Original Article Open Access
    Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma
    Wei Wang, Rui Zhang, Ning Feng, Longzhen Zhang, Nianli Liu
    Journal of Clinical and Translational Hepatology, Published online July 13, 2022. doi:10.14218/JCTH.2022.00166
    Abstract
    Emerging evidence suggests that RNA-binding motif (RBM) proteins are involved in hepatocarcinogenesis and act either as oncogenes or tumor suppressors. The objective of this study [...] Read more.

    Emerging evidence suggests that RNA-binding motif (RBM) proteins are involved in hepatocarcinogenesis and act either as oncogenes or tumor suppressors. The objective of this study was to investigate the role of RBM34, an RBM protein, in hepatocellular carcinoma (HCC).

    We first examined the expression of RBM34 across cancers. The correlation of RBM34 with clinicopathological features and the prognostic value of RBM34 for HCC was then investigated. Functional enrichment analysis of RBM34-related differentially expressed genes (DEGs) was performed to explore its biological function. RNA sequencing (RNA-seq) was applied to identify downstream genes and pathways affected upon RBM34 knockout. The correlation of RBM34 with immune characteristics was also analyzed. The oncogenic function of RBM34 was examined in in vitro and in vivo experiments.

    RBM34 was highly expressed in hepatocellular carcinoma and correlated with poor clinicopathological features and prognosis. RBM34 was positively associated with tumor immune cell infiltration, biomarkers of immune cells, and immune checkpoint expression. A positive correlation was also observed between RBM34, T cell exhaustion, and regulatory T cell marker genes. Knockout of RBM34 significantly inhibited cell proliferation, migration, and xenograft tumor growth, and sensitized HCC cells to sorafenib treatment. RBM34 inhibition reduced FGFR2 expression and affected PI3K-AKT pathway activation in HCC cells.

    Our study suggests that RBM34 may serve as a new prognostic marker and therapeutic target of HCC.

    Full article
    Original Article Open Access
    Naringenin is a Potential Immunomodulator for Inhibiting Liver Fibrosis by Inhibiting the cGAS-STING Pathway
    Li Chen, Siwei Xia, Shuqi Wang, Yuanyuan Zhou, Feixia Wang, Zhanghao Li, Yang Li, Desong Kong, Zili Zhang, Jiangjuan Shao, Xuefen Xu, Feng Zhang, Shizhong Zheng
    Journal of Clinical and Translational Hepatology, Published online April 28, 2022. doi:10.14218/JCTH.2022.00120
    Abstract
    Naringenin is an anti-inflammatory flavonoid that has been studied in chronic liver disease. The mechanism specific to its antifibrosis activity needs further investigation This [...] Read more.

    Naringenin is an anti-inflammatory flavonoid that has been studied in chronic liver disease. The mechanism specific to its antifibrosis activity needs further investigation This study was to focused on the cyclic guanosine monophosphate-adenosine monophosphate synthase (cGAS) pathway in hepatic stellate cells and clarified the antifibrosis mechanism of naringenin.

    The relationship between the cGAS-stimulator of interferon genes (STING) pathway and liver fibrosis was analyzed using the Gene Expression Omnibus database. Histopathology, immunohistochemistry, fluorescence staining, Western blotting and polymerase chain reaction were performed to assess gene and protein expression levels associated with the cGAS pathway in clinical liver tissue samples and mouse livers. Molecular docking was performed to evaluate the relationship between naringenin and cGAS, and western blotting was performed to study the expression of inflammatory factors downstream of cGAS in vitro.

    Clinical database analyses showed that the cGAS-STING pathway is involved in the occurrence of chronic liver disease. Naringenin ameliorated liver injury and liver fibrosis, decreased collagen deposition and cGAS expression, and inhibited inflammation in carbon tetrachloride (CCl4)-treated mice. Molecular docking found that cGAS may be a direct target of naringenin. Consistent with the in vivo results, we verified the inhibitory effect of naringenin on activated hepatic stellate cells (HSCs). By using the cGAS-specific agonist double-stranded (ds)DNA, we showed that naringenin attenuated the activation of cGAS and its inflammatory factors affected by dsDNA. We verified that naringenin inhibited the cGAS-STING pathway, thereby reducing the secretion of inflammatory factors by HSCs to ameliorate liver fibrosis.

    Interrupting the cGAS-STING pathway helped reverse the fibrosis process. Naringenin has potential as an antihepatic fibrosis drug.

    Full article
Special Features

Call for Papers for Special Issue 'Practical Updates in Breast Pathology: Common and Rare Diseases'

Journal: Journal of Clinical and Translational Pathology
Special Issue: Practical Updates in Breast Pathology: Common and Rare Diseases
Submission deadline: Auguest 31, 2026
Publication date: An article will be published online as soon as it is accepted

Call for Papers for Special Issue 'Advances in Digital Pathology and AI in Pathology'

Journal: Journal of Clinical and Translational Pathology
Special Issue: Advances in Digital Pathology and AI in Pathology
Submission deadline: December 31, 2025
Publication date: An article will be published online as soon as it is accepted

Call for Papers for Special Issue 'Contributions to the GYN Pathology'

Journal: Journal of Clinical and Translational Pathology
Special Issue: Contributions to the GYN Pathology
Submission deadline: March 31, 2025
Publication date: An article will be published online as soon as it is accepted

Call for Papers for Special Issue ‘New Translational Challenges in Primary Biliary Cholangitis’

Journal: Journal Clinical and Translational Hepatology
Special Issue: New Translational Challenges in Primary Biliary Cholangitis
Submission deadline: June 30, 2023
Publication date: An article will be published online as soon as it is accepted

Call for Papers for Special Issue ‘A Spotlight on Progress and Pitfalls in NAFLD/MAFLD Studies, 2022’

Journal: Journal of Clinical and Translational Hepatology
Special Issue: A Spotlight on Progress and Pitfalls in NAFLD/MAFLD Studies, 2022
Submission deadline: March 30, 2023
Publication date: An article will be published online as soon as it is accepted

Call for Papers for Special Issue 'Comparative study of traditional medicine in the world'

Journal: Future Integrative Medicine
Special Issue: Comparative study of traditional medicine in the world
Submission deadline: June 30, 2023
Publication date: An article will be published online as soon as it is accepted

Call for Papers for Special Issue 'Therapeutic effects of herbal medicines on neurological impairment and related mental disorders based on the evidence of clinical and basic studies'

Journal: Future Integrative Medicine
Special Issue: Therapeutic effects of herbal medicines on neurological impairment and related mental disorders based on the evidence of clinical and basic studies
Submission deadline: June 30, 2023
Publication date: An article will be published online as soon as it is accepted

Call for Papers for Special Issue ‘Immunoregulatory Mechanisms of Herbal Medicines in Cancer and Infectious Diseases’

Journal: Future Integrative Medicine
Special Issue: Immunoregulatory Mechanisms of Herbal Medicines in Cancer and Infectious Diseases
Submission deadline: June 30, 2023
Publication date: An article will be published online as soon as it is accepted
Back to Top